학술논문
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements
Document Type
Article
Author
Schram, A.M.; Shameem, S.H.; Chauhan, T.; O’reilly, E.M.; Drilon, A.; Odintsov, I.; Sisso, W.J.; Lui, A.J.W.; Vojnic, M.; Ladanyi, M.; Somwar, R.; Espinosa-Cotton, M.; Khodos, I.; Mattar, M.S.; de Stanchina, E.; Torrisi, J.; Ford, J.; O’connor, M.N.; Geuijen, C.A.W.; Schackmann, R.C.J.; van Bueren, J.J.L.; Wasserman, E.
Source
In: Cancer Discovery . (Cancer Discovery, 1 May 2022, 12(5):1233-1247)
Subject
Language
English
ISSN
21598290
21598274
21598274